Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
602
-
Total 13F shares, excl. options
-
72.3M
-
Shares change
-
-679K
-
Total reported value, excl. options
-
$32.3B
-
Value change
-
-$332M
-
Put/Call ratio
-
1.15
-
Number of buys
-
285
-
Number of sells
-
-268
-
Price
-
$447.12
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2017
713 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2017.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 602 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.3M shares
of 105M outstanding shares and own 68.91% of the company stock.
Largest 10 shareholders include FMR LLC (6.99M shares), Capital World Investors (6.57M shares), BlackRock Inc. (6.13M shares), VANGUARD GROUP INC (5.4M shares), WELLINGTON MANAGEMENT GROUP LLP (4.85M shares), STATE STREET CORP (3.24M shares), SANDS CAPITAL MANAGEMENT, LLC (2.64M shares), LOOMIS SAYLES & CO L P (1.87M shares), BANK OF AMERICA CORP /DE/ (1.61M shares), and JANUS HENDERSON GROUP PLC (1.55M shares).
This table shows the top 602 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.